Astrazeneca plc ADR [AZN] stock is trading at $69.68, down -0.34%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AZN shares have gain 5.21% over the last week, with a monthly amount glided 2.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astrazeneca plc ADR [NASDAQ: AZN] stock has seen the most recent analyst activity on April 15, 2025, when Exane BNP Paribas initiated its Outperform rating and assigned the stock a price target of $75. Previously, UBS upgraded its rating to Buy on February 13, 2025. On February 12, 2025, Morgan Stanley initiated with a Overweight rating. UBS upgraded its rating to a Neutral. Deutsche Bank upgraded its rating to a Hold. Deutsche Bank downgraded its rating to Sell for this stock on September 13, 2024. In a note dated May 30, 2024, Goldman initiated an Buy rating and provided a target price of $97 on this stock.
Astrazeneca plc ADR [AZN] stock has fluctuated between $61.24 and $87.68 over the past year. Currently, Wall Street analysts expect the stock to reach $84 within the next 12 months. Astrazeneca plc ADR [NASDAQ: AZN] shares were valued at $69.68 at the most recent close of the market. An investor can expect a potential return of 20.55% based on the average AZN price forecast.
Analyzing the AZN fundamentals
Astrazeneca plc ADR [NASDAQ:AZN] reported sales of 54.98B for the trailing twelve months, which represents a growth of 7.17%. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.19%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.19 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.77.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Astrazeneca plc ADR’s Current Ratio is 0.90. In addition, the Quick Ratio stands at 0.70 and the Cash Ratio stands at 0.18. Considering the valuation of this stock, the price to sales ratio is 3.93, the price to book ratio is 5.27 and price to earnings (TTM) ratio is 27.99.
